- Home
- ASRT vs ANIX Comparison
ASRT vs ANIX Comparison
Compare ASRT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ANIX
- Stock Information
- Founded
- ASRT 1995
- ANIX 1982
- Country
- ASRT United States
- ANIX United States
- Employees
- ASRT N/A
- ANIX N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- ANIX Health Care
- Exchange
- ASRT Nasdaq
- ANIX Nasdaq
- Market Cap
- ASRT 91.3M
- ANIX 91.7M
- IPO Year
- ASRT 1997
- ANIX 1987
- Fundamental
- Price
- ASRT $0.89
- ANIX $2.77
- Analyst Decision
- ASRT Strong Buy
- ANIX Strong Buy
- Analyst Count
- ASRT 4
- ANIX 2
- Target Price
- ASRT $3.19
- ANIX $8.50
- AVG Volume (30 Days)
- ASRT 908.1K
- ANIX 101.3K
- Earning Date
- ASRT 11-11-2024
- ANIX 01-14-2025
- Dividend Yield
- ASRT N/A
- ANIX N/A
- EPS Growth
- ASRT N/A
- ANIX N/A
- EPS
- ASRT N/A
- ANIX N/A
- Revenue
- ASRT $125,763,000.00
- ANIX N/A
- Revenue This Year
- ASRT N/A
- ANIX N/A
- Revenue Next Year
- ASRT $1.84
- ANIX N/A
- P/E Ratio
- ASRT N/A
- ANIX N/A
- Revenue Growth
- ASRT N/A
- ANIX N/A
- 52 Week Low
- ASRT $0.73
- ANIX $2.15
- 52 Week High
- ASRT $1.80
- ANIX $5.13
- Technical
- Relative Strength Index (RSI)
- ASRT 43.20
- ANIX 33.20
- Support Level
- ASRT $0.90
- ANIX $2.80
- Resistance Level
- ASRT $1.04
- ANIX $3.43
- Average True Range (ATR)
- ASRT 0.06
- ANIX 0.18
- MACD
- ASRT -0.00
- ANIX -0.04
- Stochastic Oscillator
- ASRT 14.84
- ANIX 11.84
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.